140 related articles for article (PubMed ID: 6127780)
1. Topical treatment of seasonal allergic rhinitis with a beta-adrenoceptor stimulant (KWD 2131).
Svensson G
Rhinology; 1982 Sep; 20(3):159-66. PubMed ID: 6127780
[TBL] [Abstract][Full Text] [Related]
2. Effects of topical use of beta-adrenoceptor stimulants on nasal mucosa. Rhinomanometric evaluations in experiments with terbutaline and KWD 2131. II. Nasal provocation tests with hay fever patients in asymptomatic period.
Svensson G
Acta Otolaryngol; 1980; 90(1-2):130-8. PubMed ID: 6108672
[TBL] [Abstract][Full Text] [Related]
3. Effects of topical use of beta-adrenoceptor stimulants of nasal mucosa. Rhinomanometric evaluations in experiments with terbutaline and KWD 2131.
Svensson G; Hegardt B; Löfkvist T
Acta Otolaryngol; 1980; 90(3-4):297-303. PubMed ID: 6110308
[TBL] [Abstract][Full Text] [Related]
4. Influence of a beta-adrenoceptor stimulant, KWD 2131, in nasal histamine provocation tests. Rhinomanometric evaluations in normal persons and patients with hay fever.
Svensson G; Hegardt B; Löfkvist T
Acta Otolaryngol; 1981; 92(5-6):535-41. PubMed ID: 6171989
[TBL] [Abstract][Full Text] [Related]
5. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
[TBL] [Abstract][Full Text] [Related]
6. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
Ahlström-Emanuelsson C; Andersson M; Persson C; Schrewelius C; Greiff L
Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
[TBL] [Abstract][Full Text] [Related]
7. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
Pullerits T; Lindén A; Malmhäll C; Lötvall J
Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
[TBL] [Abstract][Full Text] [Related]
8. Two-dose beclomethasone dipropionate aerosol in the treatment of seasonal allergic rhinitis.
Nuutinen J; Ruoppi P; Sorri M; Suonpää J; Vainio-Mattila J
Rhinology; 1983 Jun; 21(2):165-72. PubMed ID: 6351231
[TBL] [Abstract][Full Text] [Related]
9. Grass pollen-induced hay fever treated with a new steroid fluocortin butylester (FCB).
Moesgaard Nielsen V; Vinther B; Illum P
Rhinology; 1983 Sep; 21(3):257-63. PubMed ID: 6356306
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the inhibition of allergen-induced intracutaneous reactions by a new beta-agonist, KWD 2131, and by terbutaline.
Hegardt B; Arner B
Eur J Respir Dis; 1981 Oct; 62(5):352-9. PubMed ID: 6124440
[TBL] [Abstract][Full Text] [Related]
11. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults.
Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G
Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710
[TBL] [Abstract][Full Text] [Related]
12. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
Fokkens WJ; Jogi R; Reinartz S; Sidorenko I; Sitkauskiene B; van Oene C; Faris MA; Ellsworth A; Caldwell MF
Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
[TBL] [Abstract][Full Text] [Related]
14. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit.
Krug N; Hohlfeld JM; Geldmacher H; Larbig M; Heermann R; Lavallee N; Nguyen DT; Petzold U; Hermann R
Allergy; 2005 Mar; 60(3):354-9. PubMed ID: 15679722
[TBL] [Abstract][Full Text] [Related]
15. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
Hordijk GJ; Antvelink JB; Luwema RA
Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of loratadine versus placebo in the prophylactic treatment of seasonal allergic rhinitis.
Dolovich J; Moote DW; Mazza JA; Clermont A; PetitClerc C; Danzig M
Ann Allergy; 1994 Sep; 73(3):235-9. PubMed ID: 8092558
[TBL] [Abstract][Full Text] [Related]
17. Double-blind controlled crossover trial of 4% intranasal sodium cromoglycate solution in patients with seasonal allergic rhinitis.
Chandra RK; Heresi G; Woodford G
Ann Allergy; 1982 Sep; 49(3):131-4. PubMed ID: 6126145
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected.
Kita H; Jorgensen RK; Reed CE; Dunnette SL; Swanson MC; Bartemes KR; Squillace D; Blomgren J; Bachman K; Gleich GJ
J Allergy Clin Immunol; 2000 Sep; 106(3):521-9. PubMed ID: 10984373
[TBL] [Abstract][Full Text] [Related]
19. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
Dahl R; Nielsen LP; Kips J; Foresi A; Cauwenberge P; Tudoric N; Howarth P; Richards DH; Williams M; Pauwels R;
Allergy; 2005 Jul; 60(7):875-81. PubMed ID: 15932376
[TBL] [Abstract][Full Text] [Related]
20. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
Kurowski M; Kuna P; Górski P
Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
